Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trial
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00239-5/abstract?dgcid=raven_jbs_etoc_feature_lanhiv
A field of possibilities for paediatric HIV
The Lancet HIV
https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00304-2/fulltext?dgcid=raven_jbs_etoc_email
Nov 2025
Volume 12Number 11e737-e810
https://www.thelancet.com/journals/lanhiv/issue/vol12no11/PIIS2352-3018(25)X0011-4
The Academy of Medical Sciences & The Lancet International Health Lecture 2025
https://acmedsci.ac.uk/more/events/IHL-2025?utm_source=lancet&utm_medium=email&utm_campaign=ihl-25
Tuesday 4 November 2025, 15.30 GMT
1 Birdcage Walk, London
No hay comentarios:
Publicar un comentario